Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease. [electronic resource]
Producer: 20160630Description: 1103-10 p. digitalISSN:- 1875-8908
- Aged
- Alzheimer Disease -- blood
- Amyloid beta-Peptides -- blood
- Analysis of Variance
- Clusterin -- blood
- Cognition Disorders -- complications
- Disease Progression
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neuropsychological Tests
- Peptide Fragments -- blood
- Predictive Value of Tests
- Proportional Hazards Models
- Psychiatric Status Rating Scales
- tau Proteins -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.